Related references
Note: Only part of the references are listed.Endogenous APOBEC3B Restricts LINE-1 Retrotransposition in Transformed Cells and Human Embryonic Stem Cells
Silke Wissing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of a Single Amino Acid Required for APOBEC3 Antiretroviral Cytidine Deaminase Activity
Ying Dang et al.
JOURNAL OF VIROLOGY (2011)
Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1
Judd F. Hultquist et al.
JOURNAL OF VIROLOGY (2011)
Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
Xiaojun Wang et al.
JOURNAL OF VIROLOGY (2011)
APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells
Gregory Berger et al.
PLOS PATHOGENS (2011)
Regulation of mRNA Translation and Stability by microRNAs
Marc Robert Fabian et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
John S. Albin et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity
Anjie Zhen et al.
JOURNAL OF VIROLOGY (2010)
The Range of Human APOBEC3H Sensitivity to Lentiviral Vif Proteins
Melody M. H. Li et al.
JOURNAL OF VIROLOGY (2010)
Lentiviral Vif Degrades the APOBEC3Z3/APOBEC3H Protein of Its Mammalian Host and Is Capable of Cross-Species Activity
Rebecca S. LaRue et al.
JOURNAL OF VIROLOGY (2010)
Stably Expressed APOBEC3F Has Negligible Antiviral Activity
Eri Miyagi et al.
JOURNAL OF VIROLOGY (2010)
Moderate Influence of Human APOBEC3F on HIV-1 Replication in Primary Lymphocytes
Lubbertus C. F. Mulder et al.
JOURNAL OF VIROLOGY (2010)
The Localization of APOBEC3H Variants in HIV-1 Virions Determines Their Antiviral Activity
Marcel Ooms et al.
JOURNAL OF VIROLOGY (2010)
Long-Term Restriction by APOBEC3F Selects Human Immunodeficiency Virus Type 1 Variants with Restored Vif Function
John S. Albin et al.
JOURNAL OF VIROLOGY (2010)
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Mark D. Stenglein et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Eric W. Refsland et al.
NUCLEIC ACIDS RESEARCH (2010)
Analysis of the Percentage of Human Immunodeficiency Virus Type 1 Sequences That Are Hypermutated and Markers of Disease Progression in a Longitudinal Cohort, Including One Individual with a Partially Defective Vif
Anne Piantadosi et al.
JOURNAL OF VIROLOGY (2009)
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Fransje A. Koning et al.
JOURNAL OF VIROLOGY (2009)
Reassessing the Role of APOBEC3G in Human Immunodeficiency Virus Type 1 Infection of Quiescent CD4+T-Cells
Masakazu Kamata et al.
PLOS PATHOGENS (2009)
HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC
Natasha Wood et al.
PLOS PATHOGENS (2009)
HIV-1 accessory proteins - Ensuring viral survival in a hostile environment
Michael H. Malim et al.
CELL HOST & MICROBE (2008)
Antiretroelement activity of APOBEC3H was lost twice in recent human evolution
Molly OhAinle et al.
CELL HOST & MICROBE (2008)
Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G
Guylaine Hache et al.
CURRENT BIOLOGY (2008)
Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya
Allison M. Land et al.
JOURNAL OF VIROLOGY (2008)
The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction
April J. Schumacher et al.
JOURNAL OF VIROLOGY (2008)
Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells
Gustavo H. Kijak et al.
VIROLOGY (2008)
Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors
Shiv K. Gandhi et al.
JOURNAL OF VIROLOGY (2008)
Vpr.A3A chimera inhibits HIV replication
Renato S. Aguiar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism
Mariana Marin et al.
JOURNAL OF VIROLOGY (2008)
Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins
Cesar A. Virgen et al.
JOURNAL OF VIROLOGY (2007)
Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1
Eri Miyagij et al.
JOURNAL OF VIROLOGY (2007)
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2007)
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F
Rebecca A. Russell et al.
JOURNAL OF VIROLOGY (2007)
Genetic knockouts and knockins in human somatic cells
Carlo Rago et al.
NATURE PROTOCOLS (2007)
Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family
Ying Dang et al.
JOURNAL OF VIROLOGY (2006)
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Hal P. Bogerd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
HP Bogerd et al.
NUCLEIC ACIDS RESEARCH (2006)
Natural variation in Vif: Differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification
Viviana Simon et al.
PLOS PATHOGENS (2005)
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
BP Doehle et al.
VIROLOGY (2005)
Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G
KM Rose et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
TL Kieffer et al.
JOURNAL OF VIROLOGY (2005)
Recovery of APOBEC3-edited human immunodeficiency virus G -> A hypermutants by differential DNA denaturation PCR
R Suspene et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities
MA Langlois et al.
NUCLEIC ACIDS RESEARCH (2005)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
MT Liddament et al.
CURRENT BIOLOGY (2004)
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
Q Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
HL Wiegand et al.
EMBO JOURNAL (2004)
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
YH Zheng et al.
JOURNAL OF VIROLOGY (2004)
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Q Yu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Sexual transmission of HIV-1 isolate showing G -> A hypermutation
E Caride et al.
JOURNAL OF CLINICAL VIROLOGY (2002)
Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells
M Janini et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
